Decoding OOoATL2: How O-GlcNAcylation Impacts the LATS2 Pathway
O-GlcNAcylation on LATS2 directly disrupts the Hippo signaling pathway by suppressing its kinase activity. This specific post-translational modification acts as a metabolic switch that overrides the body’s natural cellular breaks. In a healthy physiological state, the Hippo pathway serves as a vital regulator of organ size, tissue homeostasis, and cell death. However, when cellular nutrient levels fluctuate, a sugar-driven modification known as O-GlcNAcylation compromises LATS2 (Large Tumor Suppressor Kinase 2), leading to uninhibited cellular proliferation and tumor growth. The Core Players: Hippo, LATS2, and O-GlcNAcylation
To understand how the pathway breaks down, it is essential to map the standard molecular cascade:
The Hippo Cascade: Under baseline conditions, upstream kinases (like MST1/2) activate the core kinases LATS1 and LATS2.
The Brake System: Activated LATS2 phosphorylates two powerful downstream transcription co-activators: YAP and TAZ. Phosphorylation traps YAP/TAZ in the cytoplasm or targets them for degradation, halting cell growth.
The Metabolic Sugar Hook: O-GlcNAcylation is a dynamic process where a single sugar molecule (O-linked
-N-acetylglucosamine) is attached to the serine or threonine residues of nuclear and cytoplasmic proteins. Driven by the hexosamine biosynthetic pathway, it acts as a direct sensor of cellular nutrient status and glucose abundance. The Molecular Sabotage: How LATS2 is Silenced
Researchers tracking the intersection of metabolism and oncology discovered that abnormally high levels of global O-GlcNAcylation specifically target LATS2, effectively silencing its tumor-suppressive capabilities. 1. Disruption at Thr436
The primary mechanism of inhibition occurs when O-GlcNAc transferase (OGT) attaches a sugar moiety to the Threonine 436 (Thr436) residue of the LATS2 protein. 2. The MOB1 Bridge Collapse
Physiologically, LATS2 requires a physical interaction with its crucial adaptor protein, MOB1, to connect with upstream activating signals. The bulky sugar molecule at the Thr436 site creates steric hindrance, completely blocking the LATS2-MOB1 interaction. 3. Failure of Self-Phosphorylation
Because LATS2 cannot bind to MOB1, it cannot be successfully phosphorylated at its hydrophobic motif (specifically at Thr1041). Without this step, LATS2 remains inactive and inert. Downstream Consequences: Hyperactivating YAP/TAZ
When O-GlcNAcylation compromises LATS2, the downstream molecular breaks fail entirely.
[High Glucose / OGT Activation] │ ▼ O-GlcNAcylation at LATS2 (Thr436) │ ▼ (Blocks MOB1 Binding) LATS2 Inactivation │ ▼ (Loss of Phosphorylation) YAP / TAZ Hyperactivation │ ▼ [Uncontrolled Proliferation & Tumor Growth]
Because inactive LATS2 cannot phosphorylate YAP and TAZ, these two proteins freely translocate into the cell nucleus. Once in the nucleus, they bind to TEAD transcription factors and launch a massive gene expression program. This induces the transcription of oncogenic targets like CTGF and CYR61, accelerating cell division, migration, and survival. Short-Circuiting the Negative Feedback Loop
In a healthy system, the Hippo pathway features a built-in safety valve. When YAP and TAZ become active, they naturally induce the transcription of LATS2 and NF2 to synthesize new proteins that turn the pathway back “off”.
However, under high metabolic stress or malignant conditions, this feedback loop is short-circuited. Even though hyperactive YAP/TAZ prompt the cell to manufacture more LATS2 protein, any newly synthesized LATS2 is immediately targeted and modified by O-GlcNAcylation at the Thr436 site. The safety brake is essentially stripped of its gears as fast as the cell can produce it. Therapeutic Implications
Unearthing the structural mechanism of LATS2 O-GlcNAcylation exposes a major vulnerability in hyper-metabolic cancers, including breast and liver malignancies.
Leave a Reply